Why this resource exists
About
Gentle Clearing 15 exists to make difficult health claims easier to examine without adding pressure, certainty, or sales language. Sage Aperture is an independent resource on ibogaine and anxiety, distinguishing early findings from established care. It helps people understand evidence limits, safety concerns, and unanswered questions.
A useful resource makes room for uncertainty rather than hiding it.
Our editorial approach
Start with what can be checked.
We organize information around questions people actually encounter: what is known, what remains preliminary, what safety issues deserve attention, and which claims exceed the available support. Our starting point is the careful overview on the main evidence page, then each section separates sources, interpretation, and uncertainty as clearly as possible.
Information is checked against research literature, clinical trial registries, and official sources where they are available. Trial records can be reviewed through the U.S. clinical studies registry; this helps distinguish a registered investigation from an established intervention.
“The point is not to make a decision for someone. It is to make the limits of the information visible.”
What we cover
A route through the questions, not a push toward an answer.
Our pages collect general context, evidence summaries, safety considerations, and the questions people may want to raise with qualified professionals. The ways this resource is organized are intended to help readers move from a broad claim to the supporting material without implying that information alone is personal guidance.
We also point readers to adjacent questions that can affect how claims are interpreted, including ibogaine and alcohol addiction, claims around extreme alcohol use, and accounts of possible ibogaine aftereffects. These references are context, not endorsements.
When language concerns mood or treatment outcomes, we aim to name uncertainty plainly. Readers comparing related claims may encounter material on ibogaine for depression, broader addiction-treatment questions, or arguments about whether ibogaine treatment works. Each deserves its own evidence review rather than a borrowed conclusion.
How we work
Editorial principles
These commitments guide what we include, how we describe it, and what we decline to imply.
- Evidence before hype We distinguish a finding, a hypothesis, and a marketing claim rather than treating them as interchangeable.
- Risk clarity Potential harms and evidence gaps belong beside potential benefits, not in a footnote.
- Plain language Technical material is translated carefully, while its limits remain visible.
- Scientific humility We avoid presenting incomplete evidence as certainty and update framing when stronger sources warrant it.
- Independence We are not a clinic, medical provider, licensed treatment center, or legal authority. Our role is informational only.
Independent sourcing matters because research participation, study design, and publication practices can shape what a reader sees. The National Library of Medicine’s research archive is one useful place to locate published biomedical literature, while source quality still requires careful reading.
Independent by design
For people seeking context—not a sales path.
Gentle Clearing 15 is for patients, families, and anyone trying to sort strong claims from limited evidence. We recognize that people may be looking for answers under difficult circumstances; that is a reason for greater care, not greater certainty.
Questions about cost can also shape the search process, which is why references to affordable ibogaine treatment should be read as part of a broader context of evidence, safety, and informed decision-making—not as an invitation or recommendation.
See how the resource is structured“Clear information should help a reader notice what is known, what is missing, and what needs qualified advice.”